posted on 2021-06-15, 22:58authored bySofia Thomaidou, Roderick C. Slieker, Arno R. van der Slik, Jasper Boom, Flip Mulder, Amadeo Munoz-Garcia, Leen M. ‘t Hart, Bobby Koeleman, Francoise Carlotti, Rob C. Hoeben, Bart O. Roep, Hailiang Mei, Arnaud Zaldumbide
Type 1 diabetes is an autoimmune disease characterized by autoreactive
T-cell mediated destruction of the insulin-producing pancreatic beta-cells.
Increasing evidence suggest that the beta-cells themselves contribute to their
own destruction by generating neo-antigens through the production of aberrant
or modified proteins that escape central tolerance. We have recently
demonstrated that ribosomal infidelity amplified by stress could lead to the
generation of neoantigens in human beta-cells, emphasizing the participation of
nonconventional translation events to autoimmunity, as occurring in cancer or
virus-infected tissues. Using a transcriptome-wide profiling approach to map
translation initiation start sites in human beta-cells under standard and
inflammatory conditions, we identify a completely new set of polypeptides
derived from non-canonical start sites and translation initiation within
lncRNA. Our data underline the extreme diversity of the beta-cell translatome
and may reveal new functional biomarkers for beta-cell distress, disease
prediction and progression and therapeutic intervention in type 1 diabetes.
Funding
This work is supported by JDRF, DON and the Dutch Diabetes Research Foundation and by the IMI2-JU under grant agreement No 115797 (INNODIA) and No 945268 (INNODIA HARVEST). This Joint Undertaking receives support from the Union’s Horizon 2020 research and innovation program and “EFPIA”, ‘JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”. BOR is supported by the Wanek Family Project for Type 1 Diabetes.